Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tristan Mirault1, Henri Guillet1, Emmanuel Messas1

  • 1Rare Vascular Diseases French National Reference Center, hôpital européen Georges-Pompidou, AP-HP, Paris Descartes University, Sorbonne Paris Cité, PARCC, Department of Vascular Medicine, Inserm U970, 75015 Paris, France.

Presse Medicale (Paris, France : 1983)
|August 15, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of venous thromboembolism in France - a nationwide clinical practice survey among vascular medicine specialists.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same author

Dosage of lipoproteins for risk management according to guidelines.

Vascular diseases (Paris, France)·2026
Same author

Machine Learning for Cardiovascular Prevention Prescriptions: Real-World vs. Synthetic Data.

Studies in health technology and informatics·2026
Same author

The effects of aging on left ventricular diastolic function evaluated with 4D flow MRI: a novel approach using mitral velocity and propagation velocity measurements.

Physiological measurement·2026
Same author

Takayasu arteritis phenotypes and outcomes: A data-driven cluster analysis from a large international cohort.

Journal of autoimmunity·2026
Same author

How French vascular physicians treat cancer associated superficial vein thrombosis?

Vascular diseases (Paris, France)·2026
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Takayasu arteritis (TAK) involves immune cells attacking large arteries, causing vessel damage. Understanding these complex pathways is key to developing targeted therapies for this rare vasculitis.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Rheumatology

Background:

  • Takayasu arteritis (TAK) is a serious large-vessel vasculitis affecting arteries.
  • The condition involves an immune response targeting the arterial wall, including dendritic cells, endothelial cells, smooth muscle cells, and fibroblasts.
  • This interaction with T cells and macrophages leads to vessel stenosis or aneurysmal damage.

Purpose of the Study:

  • To elucidate the physiopathological pathways and mechanisms underlying Takayasu arteritis.
  • To identify key cellular interactions and molecular mediators involved in disease progression.
  • To lay the groundwork for more targeted therapeutic strategies in TAK.

Main Methods:

  • Review and synthesis of existing literature on Takayasu arteritis.

Related Experiment Videos

  • Analysis of cellular components and immune interactions within the arterial wall.
  • Identification of implicated cytokines and their correlation with disease activity.

    • Main Results:

    • TAK involves a complex interplay between vascular cells (dendritic cells, endothelial cells, smooth muscle cells, fibroblasts) and immune cells (T cells, macrophages).
    • Numerous cytokines are elevated in TAK and correlate with disease activity.
    • The immune-mediated damage results in luminal stenosis or aneurysmal changes in affected arteries.

    Conclusions:

    • A deeper comprehension of TAK's pathophysiology is essential.
    • Understanding cellular and molecular mechanisms can guide the development of personalized treatments.
    • Targeting specific pathways may improve therapeutic outcomes for patients with Takayasu arteritis.